Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Genentech patent opposition analysis

Get Patent Opposition Report for Genentech

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Genentech opposed by its competitors

Explore Genentech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2694072Aug 7, 2024Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use1
EP4108259Jan 3, 2024Process For Concentration Of Antibodies And Therapeutic Products Thereof1
EP3589661Nov 1, 2023Adjuvant Treatment Of Her2-Positive Breast Cancer4
EP2784084Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof5
EP3597659Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides9
EP3805248Jan 18, 2023Process For Concentration Of Antibodies And Therapeutic Products Thereof2
EP3401335Jun 30, 2021Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof5
EP3337812Apr 28, 2021Method For The Reduction Of Host Cell Proteins In Affinity Chromatography4
EP3570884Sep 30, 2020Subcutaneous Her2 Antibody Formulations4
EP1543038Aug 5, 2020Protein Purification1

Top competitors of Genentech